Gabriela Bosco

Gabriela Bosco


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PFPatricia Fernandez-Sanjuan
Patricia Fernandez-Sanjuan
JAJuan José Arrieta
Juan José Arrieta
JSJaime Sanabria
Jaime Sanabria
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
GBGabriela Bosco
Gabriela Bosco
GPGuillermo Plaza
Guillermo Plaza
Mandibular advancement devices (MAD) are an effective alternative treatment to CPAP. Different maneuvers were performed during drug sleep-induced endoscopy (DISE) to mimic the effect of MAD. Using the Selector Avance Mandibular (SAM) device, we aimed to identify MAD candidates during DISE using a titratable, reproducible, and measurable maneuver. This DISE-SAM protocol may help to find the relationship between the severity of the respiratory disorder and the degree of response and determine the advancement required to improve the collapsibility of the upper airway. Explorations were performed in 161 patients (132 males; 29 females) with a mean age of 46.81 (SD = 11.42) years, BMI of 27.90 (SD = 4.19) kg/m2, and a mean AHI of 26.51 (SD = 21.23). The results showed no relationship between severity and MAD recommendation. Furthermore, there was a weak positive relationship between the advancement required to obtain a response and the disease severity. Using the DISE-SAM protocol, the response and the range of mandibular protrusion were assessed, avoiding the interexaminer bias of the jaw thrust maneuver. We suggest prescribing MAD as a single, alternative, or multiple treatment approaches following the SAM recommendations in a personalized design.

20 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GBGabriela Bosco
Gabriela Bosco
MMMarta Morato
Marta Morato
NPNuria Perez
Nuria Perez
ANAndres Navarro
Andres Navarro
MRMiguel A. Racionero
Miguel A. Racionero
GPGuillermo Plaza
Guillermo Plaza
We report the results of one-stage multilevel upper airway surgery for patients who could not tolerate continuous positive airway pressure (CPAP). Patients treated with multilevel surgery at a University Hospital in 2015–2019 were identified from a prospectively maintained database. The inclusion criteria were aged 18–70 years, body mass index (BMI) < 35 kg/m2, apnea–hypopnea index (AHI) > 20, and lingual tonsil hypertrophy grade 3 or 4. Drug-induced sleep endoscopy was performed before surgery in all patients. Multilevel surgery was performed in one stage and included expansion sphincter pharyngoplasty (ESP), coblation tongue base reduction (CTBR), and partial epiglottectomy (PE) as required. The outcome measures were postoperative AHI, time percentage oxygen saturation < 90%, and Epworth Sleepiness Scale (ESS) score. A total of 24 patients were included: median age 49.1 years, average BMI 27.26 kg/m2, and 90% men. Ten patients received ESP plus CTBR plus PE, eight received ESP plus CTBR, and six received ESP plus PE. The mean preoperative AHI was 33.01 at baseline and improved to 17.7 ± 13 after surgery (p < 0.05). The ESS score decreased from 11 ± 5.11 to 7.9 ± 4.94 (p < 0.05). The surgical success rate according to Sher’s criteria was 82.3%. The median follow-up was 23.3 months (range 12–36). These findings suggest that multilevel surgery is a safe and successful treatment of OSAHS.

20 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PFPatricia Fernandez-Sanjuan
Patricia Fernandez-Sanjuan
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
GBGabriela Bosco
Gabriela Bosco
NPNuria Perez
Nuria Perez
MGMarta Morato Galan
Marta Morato Galan
GPGuillermo Plaza
Guillermo Plaza
Background: Mandibular advancement devices (MADs) are an effective treatment for patients with sleep-related breathing disorders, with variable response. Increasingly more research points to the predictive value of Drug-Induced Sleep Endoscopy (DISE) in patient selection. This study aims to analyze the changes in upper airway collapsibility using a titratable MAD simulator during DISE. Methods: This study included 104 patients with simple snoring and obstructive sleep apnea (OSA). The VOTE scale was used to assess the presence of collapses during the DISE both without and with the MAD simulator. Results: In snorers, there was a decrease in collapses at the level of the soft palate and oropharynx when the advancement was achieved. Patients with mild OSA also showed a decrease in collapses at the base of the tongue. Patients with moderate/severe OSA exhibited significant amelioration at all levels. The levels at which there were residual collapses despite the maneuver were, in order, the velopharynx, oropharynx, epiglottis, and tongue. Conclusions: The MAD simulator reduces collapsibility at all levels and in all severity groups. Residual collapses suitable for combined treatments were able to be identified. This highlights the need for individualized patient selection, as upper airway collapsibility exhibits variable improvement or worsening with the MAD simulator regardless of the severity of the condition.

1 July 2019 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
GBGabriela Bosco
Gabriela Bosco
NPNuria Pérez-Martín
Nuria Pérez-Martín
MRMiguel A. Racionero
Miguel A. Racionero
GPGuillermo Plaza
Guillermo Plaza